Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
0.293
+0.033 (12.77%)
At close: Nov 22, 2024, 4:00 PM
0.275
-0.018 (-6.21%)
After-hours: Nov 22, 2024, 7:53 PM EST
Syros Pharmaceuticals Employees
Syros Pharmaceuticals had 68 employees as of December 31, 2023. The number of employees decreased by 49 or -41.88% compared to the previous year.
Employees
68
Change (1Y)
-49
Growth (1Y)
-41.88%
Revenue / Employee
$5,676
Profits / Employee
-$1,438,456
Market Cap
7.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| XWELL | 337 |
| Intelligent Bio Solutions | 50 |
| Brainstorm Cell Therapeutics | 29 |
| BioCardia | 20 |
| Plus Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Edesa Biotech | 16 |
| Cardio Diagnostics Holdings | 9 |
SYRS News
- 9 days ago - Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default - Benzinga
- 10 days ago - Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression - Business Wire
- 18 days ago - The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Related Infractions - Accesswire
- 19 days ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm - Accesswire
- 20 days ago - The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations - Accesswire
- 22 days ago - Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm - Accesswire
- 22 days ago - Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire